Bias as a threat to the validity of cancer molecular-marker research
作者： David F. Ransohoff
DOI: 10.1038/NRC1550
关键词: Molecular marker 、 Psychology 、 Computational biology 、 Omics 、 Cancer 、 Interpretation (philosophy) 、 Cancer research 、 Oncology
摘要: Claims that molecular markers can accurately diagnose cancer have recently been disputed; some prominent results not reproduced and bias has proposed to explain the original observations. As new '-omics' fields are explored assess for cancer, will increasingly be recognized as most important 'threat validity' must addressed in design, conduct interpretation of such research.
nature.com
fenyolab.org 参考文章(57)
Kevin R. Coombes, Keith A. Baggerly, Jeffrey S. Morris, Bias, Randomization, and Ovarian Proteomic Data: A Reply to "Producers and Consumers" Cancer Informatics. ,vol. 1, pp. 9- 14 ,(2005) , 10.4137/CIN.S0
Norman Hearst, Stephen B Hulley, Thomas B Newman, Warren S Browner, Steven R Cummings, Deborah Grady, Designing Clinical Research: An Epidemiologic Approach ,(1988)
James M Sorace, Min Zhan, A data review and re-assessment of ovarian cancer serum proteomic profiling BMC Bioinformatics. ,vol. 4, pp. 24- 24 ,(2003) , 10.1186/1471-2105-4-24
Alvis Brazma, Pascal Hingamp, John Quackenbush, Gavin Sherlock, Paul Spellman, Chris Stoeckert, John Aach, Wilhelm Ansorge, Catherine A. Ball, Helen C. Causton, Terry Gaasterland, Patrick Glenisson, Frank C.P. Holstege, Irene F. Kim, Victor Markowitz, John C. Matese, Helen Parkinson, Alan Robinson, Ugis Sarkans, Steffen Schulze-Kremer, Jason Stewart, Ronald Taylor, Jaak Vilo, Martin Vingron, Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature Genetics. ,vol. 29, pp. 365- 371 ,(2001) , 10.1038/NG1201-365
David F. Ransohoff, Rules of evidence for cancer molecular-marker discovery and validation Nature Reviews Cancer. ,vol. 4, pp. 309- 314 ,(2004) , 10.1038/NRC1322
Christos Sotiriou, Lajos Pusztai, Gene-expression signatures in breast cancer. The New England Journal of Medicine. ,vol. 348, pp. 1715- 1717 ,(2003) , 10.1056/NEJM200304243481716
Julie E. Buring, Sherry L. Mayrent, Charles H. Hennekens, Epidemiology in Medicine ,(1987)
D. F. Ransohoff, Developing molecular biomarkers for cancer Science. ,vol. 299, pp. 1679- 1680 ,(2003) , 10.1126/SCIENCE.1083158
Philip C Prorok, Gerald L Andriole, Robert S Bresalier, Saundra S Buys, David Chia, E David Crawford, Ronald Fogel, Edward P Gelmann, Fred Gilbert, Marsha A Hasson, Richard B Hayes, Christine Cole Johnson, Jack S Mandel, Albert Oberman, Barbara O'Brien, Martin M Oken, Sameer Rafla, Douglas Reding, Wilmer Rutt, Joel L Weissfeld, Lance Yokochi, John K Gohagan, FACE for the PLCO Project Team, Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial Controlled Clinical Trials. ,vol. 21, pp. 273- ,(2000) , 10.1016/S0197-2456(00)00098-2
Erika Check, Running before we can walk? Nature. ,vol. 429, pp. 496- 497 ,(2004) , 10.1038/429496A